Metformin inhibits development of diabetic retinopathy through inducing alternative splicing of VEGF-A

Previous studies have shown that metformin, an AMP-activated protein kinase activator widely prescribed for type 2 diabetes, is especially beneficial in cases of diabetic retinopathy (DR) with undetermined mechanisms. Here, we used a streptozotocin-induced diabetes model in mice to study the effects...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Transl Res
Autors principals: Yi, Quan-Yong, Deng, Gang, Chen, Nan, Bai, Zhi-Sha, Yuan, Jian-Shu, Wu, Guo-Hai, Wang, Yu-Wen, Wu, Shan-Jun
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040692/
https://ncbi.nlm.nih.gov/pubmed/27725874
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars